Nicholas Lydon - 23 May 2022 Form 4 Insider Report for Blueprint Medicines Corp (BPMC)

Role
Director
Signature
/s/ Ariel Hurley, Attorney-in-Fact
Issuer symbol
BPMC
Transactions as of
23 May 2022
Transactions value $
$213,053
Form type
4
Date filed
25 May 2022, 16:05
Previous filing
04 Jun 2021
Next filing
30 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BPMC Common Stock Options Exercise $213K +10.9K +27.5% $19.53 50.6K 23 May 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BPMC Stock Option (Right to Buy) Options Exercise $0 -10.9K -100% $0.00* 0 23 May 2022 Common Stock 10.9K $19.53 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on June 23, 2016 and is fully vested.